Prevalence and determinants of anemia at discharge in pediatric intensive care survivors

Camille Jutras1, Michaël Sauthier1, Marisa Tucci1

  • 1Department of Pediatrics, CHU Sainte-Justine, Montréal, Québec, Canada.

Transfusion
|March 12, 2023
PubMed

Insights

Half of pediatric intensive care unit (PICU) survivors are discharged with anemia. Anemia at admission is the strongest predictor of anemia at PICU discharge, highlighting a need for further investigation into post-discharge outcomes.

Area of Science:

  • Pediatric critical care medicine
  • Hematology
  • Neurodevelopmental outcomes

Background:

  • Restrictive transfusion practices in pediatric intensive care units (PICUs) lead to increased rates of anemia at discharge.
  • Anemia in pediatric populations may impact long-term neurodevelopmental outcomes.
  • Understanding anemia epidemiology in PICU survivors is crucial.

Purpose of the Study:

  • To describe the epidemiology of anemia at PICU discharge in a mixed cohort of pediatric and cardiac surgery survivors.
  • To identify risk factors associated with anemia at PICU discharge.

Main Methods:

  • Retrospective cohort study including 4124 PICU survivors with available discharge hemoglobin levels.
  • Data extracted from an electronic medical records database.
  • Analysis of baseline characteristics and hemoglobin levels.

Main Results:

  • 50.9% of PICU survivors were anemic at discharge.
  • Anemia was prevalent in cardiac surgery patients (53.3%), particularly acyanotic ones.
  • Anemia at admission was the strongest predictor of discharge anemia (OR: 6.51).

Conclusions:

  • Approximately half of pediatric intensive care unit survivors experience anemia upon discharge.
  • Further research is needed to understand the post-discharge course of anemia and its association with adverse long-term outcomes.
Abstract

Related Concept Videos

Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
1.0K
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
3.4K
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
67
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
4.4K
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
52
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
47